Table 4.
Immunization prophylaxis in non-immune HCWs per infection.
| Infection | Seronegative HCWs (n) | HCWs Offered the Vaccine | HCWs Who Accepted Vaccine Prophylaxis | Re-Titered HCWs | Seroconverted | GMT after Booster(s) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | Mean (95%CI) | ||
| Measles | 188 | 153 | 81.3 | 150 | 98.0 | 61 | 40.7 | 54 | 88.5 | 73.6 (62.8–118.5) |
| Mumps | 188 | 124 | 66.0 | 120 | 97.6 | 52 | 43.3 | 43 | 82.7 | 38.3 (20.5–71.5) |
| Rubella | 157 | 97 | 61.8 | 95 | 97.9 | 38 | 40.0 | 36 | 94.7 | 59.7 (37.3–97.5) |
| Varicella | 111 | 82 | 73.8 | 77 | 93.9 | 29 | 37.7 | 25 | 86.2 | 636.2 (322.8–1297.2) |